shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    Notice of Intent to Publish a Funding Opportunity Announcement for Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 - Clinical Trial O

    NOT-NS-24-108

    Opening date 19 Jul 2024, 12:00AM

    Closing date N/A

    Funding Opportunity Number: NOT-NS-24-108

    Opportunity Category: Discretionary

    CFDA Number(s): 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders

    Cost Sharing or Matching Requirement: No

    Posted Date: Jul 19, 2024 12:00:00 AM EDT

    Closing Date: N/A

    Eligible Applicants: Public and State controlled institutions of higher education,Native American tribal governments (Federally recognized),Native American tribal organizations (other than Federally recognized tribal governments),Private institutions of higher education,State governments,Small businesses,For profit organizations other than small businesses,Others (see text field entitled "Additional Information on Eligibility" for clarification),Independent school districts,Public housing authorities/Indian housing authorities,Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,County governments

    Description: The National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Mental Health (NIMH) intend to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) that solicits applications focused on the neurological and psychiatric manifestations of infection-associated chronic illnesses, including the post-acute sequelae of COVID-19 (Neuro-PASC) as well as other chronic illnesses with a potential infectious trigger (post-treatment Lyme Disease, myalgic encephalomyelitis/chronic fatigue syndrome [ME/CFS], postural orthostatic tachycardia syndrome [POTS], post-viral fatigue syndromes, etc.). Projects that investigate common neuropsychiatric mechanisms across multiple infection-associated chronic illnesses would be of particular interest, although this is not a requirement (i.e., applications can focus on a single condition).� This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Fall 2024 with an expected application due date in Winter 2025. This NOFO will utilize the R21 activity code. Details of the planned NOFO are provided below.

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept